# How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix

> **NCT04789941** · PHASE2 · UNKNOWN · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- Locally Advanced Cervical Carcinoma

## Interventions

- **DRUG:** Cis Platinum + Irinotecan

## Key facts

- **NCT ID:** NCT04789941
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04789941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04789941, "How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04789941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*